Skip to content
Carenostics logo

Carenostics Alternatives & Competitors

12 companies similar to Carenostics — Addressing the underdiagnosis, undertreatment, and health inequities of chronic...

Companies similar to Carenostics

Renalytix logo — alternative to Carenostics

Renalytix

Transforming kidney disease care with one simple blood test.

dehaze logo — alternative to Carenostics

dehaze

Detecting chronic diseases before symptoms occur.

UpDoc logo — alternative to Carenostics

UpDoc

Pioneering Remote Patient Intervention | Augmenting Clinical Care with AI

HEALWELL AI (TSX: AIDX) logo — alternative to Carenostics

HEALWELL AI (TSX: AIDX)

AI Accelerated Preventative Healthcare

Rival Readout

Competing with Carenostics? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Tesu Health logo — alternative to Carenostics

Tesu Health

Evidence-based digital therapeutics platform for personalised management of chronic diseas...

Athelas logo — alternative to Carenostics

Athelas

Athelas is the AI-driven RCM, EHR, and ambient AI platform to grow your healthcare busines...

Suki logo — alternative to Carenostics

Suki

Building presence at the heart of care.

Revealix logo — alternative to Carenostics

Revealix

Clinical decision support platform for diabetic foot health. Risk revealed. Wounds interce...

Quest Diagnostics logo — alternative to Carenostics

Quest Diagnostics

Working together to create a healthier world, one life at a time.

Mesh Bio logo — alternative to Carenostics

Mesh Bio

Multidimensional Health Intelligence Platform for digital twin and computational biology e...

Powerful Medical logo — alternative to Carenostics

Powerful Medical

Leading the AI revolution in cardiovascular care.

NephroSant, Inc. logo — alternative to Carenostics

NephroSant, Inc.

Kidney Health Redefined

About Carenostics

Carenostics, founded in 2021, is a dynamic player in the intersection of AI, Biotechnology, and Health Care. The company is headquartered in the United States and is dedicated to overcoming the challenges of underdiagnosis, undertreatment, and health inequities in chronic disease through advanced AI and ML technologies...

Services

AI-driven clinical decision support, Early detection and intervention solutions, Deployment in health systems

Target Customers

Healthcare providers, Clinicians, Health systems, Hospitals

Business keywords

Healthcare AI, Chronic Disease Management, Clinical Decision Support, Predictive Analytics, Health Equity, Chronic Kidney Disease, Electronic Health Records, Diagnostics, Risk Stratification, Disease Intervention, Healthtech Solutions, Healthcare Partnerships, Health Inequities

Frequently Asked Questions

Companies similar to Carenostics include Renalytix, dehaze, UpDoc, HEALWELL AI (TSX: AIDX), Tesu Health. They work in AI and Health Care and share Carenostics's focus on chronic disease management, predictive analytics and clinical decision support.
Bounce Watch lists 12 companies that share Carenostics's industries and are closest to it in business tags, services, target customers, business model and size.
Carenostics, founded in 2021, is a dynamic player in the intersection of AI, Biotechnology, and Health Care. The company is headquartered in the United States and is dedicated to overcoming the challenges of underdiagnosis, undertreatment, and health inequities in chronic disease through advanced AI and ML technologies...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Carenostics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Carenostics on 18 Sep 2025. The 12 companies listed here were last checked between 12 Sep 2024 and 20 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout